MedPath

辽源誉隆亚东药业有限责任公司

Ownership
-
Established
1999-08-03
Employees
-
Market Cap
-
Website
www.liaoyuanyadong.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

260

NMPA:260

Drug Approvals

Compound Pepsin Granules

Product Name
复方胃蛋白酶颗粒
Approval Number
国药准字H22024891
Approval Date
Apr 23, 2025
NMPA

前列舒乐片

Approval Number
国药准字Z20090089
Approval Date
Feb 23, 2024
NMPA

疗癣卡西甫散

Approval Number
国药准字Z20093255
Approval Date
Feb 23, 2024
NMPA

祛瘀益胃片

Approval Number
国药准字Z20090336
Approval Date
Feb 21, 2024
NMPA

舒泌通片

Approval Number
国药准字Z20090706
Approval Date
Feb 21, 2024
NMPA

前列癃闭通片

Approval Number
国药准字Z20090682
Approval Date
Feb 21, 2024
NMPA

滇桂艾纳香胶囊

Approval Number
国药准字Z20060259
Approval Date
Dec 31, 2020
NMPA

人参茎叶皂苷片

Approval Number
国药准字Z20026645
Approval Date
Jun 18, 2020
NMPA

参芪扶正丸

Approval Number
国药准字B20020046
Approval Date
Jun 18, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z22026344
Approval Date
Jun 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 26
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.